# FDA Inspection 931265 - Galephar Pharmaceutical Research Inc. - June 11, 2015

Source: https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/b69ab604-9aad-46a9-8cd3-e8d02eeacef6
Source feed: FDA_Inspections

> FDA Inspection 931265 for Galephar Pharmaceutical Research Inc. on June 11, 2015. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 931265
- Company Name: Galephar Pharmaceutical Research Inc.
- Inspection Date: 2015-06-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273815 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/2815fac7-3c9a-4abc-a063-baf2b2f01282)
- [FDA Inspection 1273815 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/38bcab3a-e5b9-49c5-8833-2a2cb1d46fc6)
- [FDA Inspection 1273815 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/d8cdab26-f62d-471e-b6a2-da022fbc3b33)
- [FDA Inspection 1108270 - 2019-11-01](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/49cc3d4f-72d6-411a-9030-98429f83dbc9)
- [FDA Inspection 931265 - 2015-06-11](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/425adf79-22da-4d9b-8de8-1e88f02e3e5c)

Company: https://www.keypedia.com/companies/galephar-pharmaceutical-research-inc/e38305f7-c401-4d03-8aa7-1f520179a4ea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c